PT - JOURNAL ARTICLE AU - JOLANTA ZUWALA-JAGIELLO AU - MONIKA PAZGAN-SIMON AU - EUGENIA MURAWSKA-CIALOWICZ AU - KRZYSZTOF SIMON TI - Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C DP - 2017 Sep 01 TA - In Vivo PG - 1027--1034 VI - 31 IP - 5 4099 - http://iv.iiarjournals.org/content/31/5/1027.short 4100 - http://iv.iiarjournals.org/content/31/5/1027.full SO - In Vivo2017 Sep 01; 31 AB - Background/Aim: Type 2 diabetes mellitus (DM) frequently occurs in patients with chronic hepatitis C (CHC) and is associated with atherosclerosis, in which circulating microparticles (MPs) play an important role. We asked whether the presence of DM affects endothelial-derived (EMPs) and platelet-derived microparticles (PMPs) levels; and whether MPs levels associate with biomarkers of inflammation and oxidative stress in patients with CHC. Materials and Methods: Overall, 136 patients were enrolled in the study, 86 CHC patients (41 with DM with moderate glycemic control), 20 outpatients with DM and 30 controls. Circulating MPs were phenotyped by flow cytometry. Results: When the MPs levels were analyzed individually in CHC patients, there was a positive association of plasma apoptotic MPs with oxidative stress markers. We report a hitherto undescribed relationship between diabetes prevalence and apoptotic MPs-associated inflammation in patients with CHC. Conclusion: The presence of apoptotic MPs in the plasma of CHC patients, with increased levels being found in patients with DM and moderate glycemic control was herein demonstrated. The simultaneous monitoring of plasma apoptotic MPs, oxidative stress markers and inflammatory biomarkers can be helpful for the cardiovascular disease control in diabetic patients with CHC.